Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development 2022-08-08 12:24
BIO Asia-Taiwan 2022 concludes, marking another successful edition of the region's biggest bioindustry-focused conference and exhibition 2022-08-08 10:00
Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1 Small Molecule Inhibitor Prodrug ASC61 for Treatment of Advanced Solid Tumors 2022-08-08 08:10
CStone presents updated results of a registrational study of sugemalimab in patients with stage III NSCLC via oral presentation at WCLC 2022 2022-08-08 08:08
Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer 2022-08-08 08:00
Innovent Announces First Patient Dosed in Phase 1 Study of IBI324 (VEGF-A/Ang-2 Bispecific Antibody) in Patients with Diabetic Macular Edema 2022-08-08 08:00
BGI's Global Life Science Research Leadership Recognized in 2022 Nature Index 2022-08-05 22:18
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China 2022-08-04 23:30
Ascletis Announces IND Filing of Oral RdRp Inhibitor ASC10 for COVID-19 Accepted by China NMPA 2022-08-04 08:10
Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients 2022-08-03 16:50
Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines 2022-08-03 13:09
Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma 2022-08-03 08:30
Sciwind Biosciences Announces Positive Topline Results from 20-week Phase 2 Clinical Trial of XW003 (Ecnoglutide), a novel long-lasting GLP-1 analogue, in Adult Patients with Type 2 Diabetes in China 2022-08-03 08:00
Lynk Pharmaceuticals Announces IND Approval of LNK01004 for Atopic Dermatitis in China 2022-08-03 08:00
Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies 2022-08-03 08:00
Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination 2022-08-02 22:49
Metabolon Awarded ISO 9001:2015 Recertification 2022-08-02 20:57
Dr Ivan Puah Recommends Fat Grafting As A Solution Following Post-surgery Scars or Disfigurement 2022-08-02 16:41
Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency 2022-08-02 13:00
GenKOre develops hypercompact adenine base editors (ABEs) 2022-08-02 09:07
1 67 68 69 70 71 230